Too Much Pressure at the Bedside ...

[1] High versus Low Blood-Pressure Target in Patients with Septic Shock [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (17) : 1583 - 1593

[2] Administration of the nitric oxide synthase inhibitor NG-Methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis:: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002) [J]. CRITICAL CARE MEDICINE, 2004, 32 (01) : 1 - 12

[3] Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality [J]. CRITICAL CARE MEDICINE, 2011, 39 (02) : 259 - 265

[4] Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial [J]. CRITICAL CARE, 2009, 13 (06):

[5] Validation and Clinical Evaluation of a Method for Double-Blinded Blood Pressure Target Investigation in Intensive Care Medicine [J]. CRITICAL CARE MEDICINE, 2018, 46 (10) : 1626 - 1633

[6] Severe abnormalities in microvascular perfused vessel density are associated to organ dysfunctions and mortality and can be predicted by hyperlactatemia and norepinephrine requirements in septic shock patients [J]. JOURNAL OF CRITICAL CARE, 2013, 28 (04) : 538.e9 - 538.e14

[7] Angiotensin II for the Treatment of Vasodilatory Shock [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05) : 419 - 430

[8] Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature [J]. CRITICAL CARE, 2015, 19

[9] Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88:: Effect on survival in patients with septic shock [J]. CRITICAL CARE MEDICINE, 2004, 32 (01) : 21 - 30

[10] MEHTA S, 2013, CRIT CARE, V17

[1] High versus Low Blood-Pressure Target in Patients with Septic Shock [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (17) : 1583 - 1593

[2] Administration of the nitric oxide synthase inhibitor NG-Methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis:: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002) [J]. CRITICAL CARE MEDICINE, 2004, 32 (01) : 1 - 12

[3] Fluid resuscitation in septic shock: A positive fluid balance and elevated central venous pressure are associated with increased mortality [J]. CRITICAL CARE MEDICINE, 2011, 39 (02) : 259 - 265

[4] Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial [J]. CRITICAL CARE, 2009, 13 (06):

[5] Validation and Clinical Evaluation of a Method for Double-Blinded Blood Pressure Target Investigation in Intensive Care Medicine [J]. CRITICAL CARE MEDICINE, 2018, 46 (10) : 1626 - 1633

[6] Severe abnormalities in microvascular perfused vessel density are associated to organ dysfunctions and mortality and can be predicted by hyperlactatemia and norepinephrine requirements in septic shock patients [J]. JOURNAL OF CRITICAL CARE, 2013, 28 (04) : 538.e9 - 538.e14

[7] Angiotensin II for the Treatment of Vasodilatory Shock [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (05) : 419 - 430

[8] Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature [J]. CRITICAL CARE, 2015, 19

[9] Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88:: Effect on survival in patients with septic shock [J]. CRITICAL CARE MEDICINE, 2004, 32 (01) : 21 - 30

[10] MEHTA S, 2013, CRIT CARE, V17